Keywords
- Borderline Personality Disorder
- Personality Disorder
- Personality Disorder
- Dialectical Behavior Therapy
- Borderline Personality Disorder
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Key Readings
Linehan, M. M. (1993). Cognitive-behavioral treatment of borderline personality disorder. New York: Guilford Press.
Linehan, M. M. (1993). Skills training manual for treating borderline personality disorder. New York: Guilford Press.
Bateman, A., & Fonagy, P. (2004). Psychotherapy for borderline personality disorder: Mentalization based treatment. New York: Oxford University Press.
References
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., Text Revision). Washington, DC: APA.
Bateman, A., & Fonagy, P. (1999). Effectiveness of partial hospitalization in the treatment of borderline personality disorder: A randomized controlled trial. American Journal of Psychiatry, 156, 1563–1569.
Bateman, A., & Fonagy, P. (2001). Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: An 18-month follow-up. American Journal of Psychiatry, 158, 36–42.
Bateman, A., & Fonagy, P. (2003). Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care. American Journal of Psychiatry, 160(1), 169–171.
Bateman, A., & Fonagy, P. (2004). Psychotherapy for borderline personality disorder: Mentalization based treatment. New York: Oxford University Press.
Bockian, N. R., Villagran, N. E., & Porr, V. (2002). New Hope for People with Borderline Personality Disorder: Your Friendly, Authoritative Guide to the Latest in Traditional and Complementary Solutions. New York: Random House.
Bohus, M., Limberger, M. F., Frank, U., Sender, I., Gratwohl, T., & Stieglitz, R. (2001). Development of the Borderline Symptom List (BSL). Psychotherapie Psychosomatik Medizinische Psychologie, 51(5), 201–211. [Available in English at www.brtc.psych.washington.edu]
Clarkin, J., Widiger, T., Frances, A., Hurt, S., & Gilmore, M. (1983). Prototypic typology and the borderline personality disorder. Journal of Abnormal Psychology, 92, 263–275.
Cowdry, R. W., & Gardner, D. L. (1988). Pharmacotherapy of borderline personality disorder: Alprazolam, carbamezepine, trifluoperazine, and tranylcypromine. Archives of General Psychiatry, 45, 111–119.
Cowdry, R. W., Pickar, D., & Davies, R. (1985). Symptoms and EEG findings in the borderline syndrome. International Journal of Psychiatry Medicine, 15, 201–211.
De la Fuente, J. M., & Lotstra, F. (1994). A trial of carbamazepine in borderline personality disorder. European Neuropsychopharmacology, 4, 479–486.
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1997). Structured Clinical Interview for DSM-IV Personality Disorders, (SCID-II). Washington, DC: American Psychiatric Press, Inc.
Frankenburg, F. R., & Zanarini, M. C. (2002). Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: A double-blind placebo-controlled pilot study. Journal of Clinical Psychiatry, 63(5), 442–446.
Geller, J. L. (1986). In again, out again: Preliminary evaluation of a state hospital’s worst recidivists. Hospital and Community Psychiatry, 37, 386–390.
Goldberg, S. C., Schulz, S. C., Schulz, P. M., Resnick, R. J., Hamer, R. M., & Friedel, R. O. (1986). Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo. Archives of General Psychiatry, 43(7), 680–686.
Gutheil, T. G. (2004). Suicide, suicide litigation, and borderline personality disorder. Journal of Personality Disorders, 18(3), 248–256.
Gutheil, T. G., Bursztajn, H., & Brodsky, A. (1986). A multi-dimensional assessment of dangerousness: Competence assessment and liability prevention. Bulletin of the American Academy of Psychiatry Law, 14, 123–129.
Hollander, E., Allen, A., Lopez, R. P., Bienstock, C. A., Grossman, R., Siever, L. J. et al. (2001). A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. Journal of Clinical Psychiatry, 62(3), 199–203.
Hyler, S. E. (1994). Personality Questionnaire, PDQ-4+. New York: New York State Psychiatric Institute.
Klein, M. H., & Benjamin, L. S. (1996). The Wisconsin Personality Disorders Inventory-IV. Madison, WI: University of Wisconsin, unpublished test. Available from Dr. M. H. Klein, Department of Psychiatry, Wisonsin Psychiatric Institute and Clinic, 6001 Research Park Blvd., Madison, WI 53719–1179.
Kroll, J. L., Sines, L. K., & Martin, K. (1981). Borderline personality disorder: Construct validity of the concept. Archives of General Psychiatry, 39, 60–63.
Lieb, K., Zanarini, M. C., Schmahl, C., Linehan, M. M., & Bohus, M. (2004). Borderline personality disorder. The Lancet, 364, 453–461.
Linehan, M. M. (1993a). Cognitive-behavioral treatment of borderline personality disorder. New York: Guilford Press.
Linehan, M. M. (1993b). Skills training manual for treating borderline personality disorder. New York: Guilford Press.
Linehan, M. M., Armstrong, H. E., Suarez, A., Allmon, D., & Heard, H. L. (1991). Cognitivebehavioral treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry, 48, 1060–1064.
Linehan, M., Davison, G., Lynch, T., & Sanderson, C. (2005). Technique Factors in Treating Personality Disorders. In Castonguay, L., Beutler, L. (Eds.), Principles of Therapeutic Change that Work. Oxford University Press, pp. 239–252.
Linehan, M. M., Dimeff, L. A., Reynolds, S. K., Comtois, K. A., Welch, S. S., Heagerty, P., et al. (2002). Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opiod dependent women meeting criteria for borderline personality disorder. Drug & Alcohol Dependence, 67, 13–26.
Linehan, M. M., & Heard, H. L. (1999). Borderline personality disorder: Costs, course, and treatment outcomes. In N. Miller & K. M. Magruder (Eds.), Cost-effectiveness of psychotherapy (pp. 291–305). New York: Oxford University Press.
Linehan, M. M., Heard, H. L., & Amstrong, H. E. (1993). Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Archives of General Psychiatry, 50, 971–974.
Linehan, M. M., Rizvi, S. L., Welch, S., & Page, B. (1999). Suicide and personality disorders. In K. Hawton & K. van Heeringe (Eds.), International handbook of suicide and attempted suicide. Sussex, England: John Wiley & Sons, Ltd.
Linehan, M. M., Tutek, D. A., Heard, H. L., & Armstrong, H. E. (1994). Interpersonal outcome of cognitive behavioral treatment for chronically suicidal borderline patients. American Journal of Psychiatry, 151, 1771–1776.
Markovitz, P. J. (1995). Pharmacotherapy of impulsivity, aggression, and related disorders. In E. Hollander & D. J. Stein (Eds.). Impulsivity and aggression (pp. 263–287). Chichester, England: John Wiley & Sons.
Mental Health Center of Greater Manchester, NH. (1998). Gold Award: Integrating dialectical behavior therapy into a community mental health program. Psychiatric Services, 49, 1338–1340.
Modestin, J., Abrecht, I., Tschaggelar, W., & Hoffman, H. (1997). Diagnosing borderline: A contribution to the question of its conceptual validity. Archives Psychiatrica Nervenkra, 233, 359–370.
Morey, L. C. (1991). The Personality Assessment Inventory professional manual. Odessa, FL: Psychological Assessment Resources.
Paris, J. (2004). Is hospitalization useful for suicidal patients with borderline personality disorder? Journal of Personality Disorders, 18(3), 240–247.
Rinne, T., van den Brink, W., Wouters, L., van Dyck, R. (2002). SSRI treatment of borderline personality disorder: A randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. American Journal of Psychiatry, 159, 2048–2054.
Salzman, C., Wolfson, A. N., Schatzberg, A., Looper, J., Henke, R., & Albanese, M., et al. (1995). Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. Journal of Clinical Psychopharmacology, 15(1), 23–29.
Soloff, P. H. (2000). Pharmacology of borderline personality disorder. The Psychiatric Clinics of North America, 23(1), 169–192.
Soloff, P. H., Cornelius, J. R., George, A., Nathan, R. S., Perel, J. M., & Ulrich, R. F. (1993). Efficacy of phenelzine and haloperidol in borderline personality disorder. Archives of General Psychiatry, 50, 377–385.
Soloff, P. H., George, A., Swami, N., Schulz, P. M. Ulrich, R. F., & Perel, J. M. (1986). Progress in pharmacotherapy of borderline disorders: A double-blind study of amitriptyline, haloperidol, and placebo. Archives of General Psychiatry, 43, 691–697.
Surber, R. W., Winkler, E. L., Monteleone, M., Havassy, B. E., Goldfinger, S. M., & Hopkin, J. T. (1987). Characteristics of high users of acute psychiatric inpatient services. Hospital and Community Psychiatry, 38(10), 1112–1114.
Swigar, M. E., Astrachan, B., Levine, M. A., Mayfield, V., & Radovich, C. (1991). Single and repeated admissions to a mental health center: Demographic, clinical and use of service characteristics. International Journal of Social Psychiatry, 37(4), 259–266.
Tanney, B. L. (1992). Mental disorders, psychiatric patients, and suicide. In R. W. Maris, A. L. Berman, & J. T. Maltsberger (Eds.), Assessment and prediction of suicide. (pp. 277–320). New York: Guilford Press.
Thornton, M. F. (1997). Eclipses: Behind the borderline personality disorder. Monte Sano Publishing.
Torgersen, S., Kringlen, E., Cramer, V. (2001). The prevalence of personality disorders in a community sample. Archives of General Psychiatry 58, 590–596.
Widiger, T. A., & Frances, A. J. (1989). Epidemiology, diagnosis, and comorbidity of borderline personality disorder. In A. Tasman, R. E. Hales, & A. J. Frances (Eds.), American psychiatric press review of psychiatry, (Vol. 8. pp. 8–24). D.C.: American Psychiatric Press.
Widiger, T. A., & Weissman, M. M. (1991). Epidemiology of borderline personality disorder. Hospital and Community Psychiatry, 42, 1015–1021.
Woogh, C. M. (1986). A cohort through the revolving door. Canadian Journal of Psychiatry, 31 (3), 214–221.
Zanarini, M. C., & Frankenburg, F. R. (2001). Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. Journal of Clinical Psychiatry, 62(11), 849–854.
Zanarini, M. C., & Frankenburg, F. R. (2003). Omega-3 fatty acid treatment of women with borderline personality disorder: A double-blind, placebo-controlled pilot study. American Journal of Psychiatry, 160, 167–169.
Zanarini, M. C., Vujanovic, A., Parachini, E. A., Boulanger, J. L., Frankenburg, F. R. & Hennen, J. (2003). A screening measure for BPD: The McLean Screening Instrument for Borderline Personality Disorder. Journal of Personality Disorders, 17(6), 568–573.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Sayrs, J., Whiteside, U. (2006). Borderline Personality Disorder. In: Fisher, J.E., O’Donohue, W.T. (eds) Practitioner’s Guide to Evidence-Based Psychotherapy. Springer, Boston, MA . https://doi.org/10.1007/978-0-387-28370-8_14
Download citation
DOI: https://doi.org/10.1007/978-0-387-28370-8_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-28369-2
Online ISBN: 978-0-387-28370-8
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)